List of works - Francesco Rodeghiero

A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.

scientific article

A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene

scientific article

A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiency

scientific article

Advances in the diagnosis and management of type 1 von Willebrand disease ⬇️

scientific article published on February 1, 2011

Assessing bleeding in von Willebrand disease with bleeding score

scientific article published on 13 June 2006

Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?

scientific article

Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.

scientific article

Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.

scientific article

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

scientific article

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia

scientific article

Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation

scientific article

Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults

scientific article

Economic assessment of eltrombopag in the treatment of thrombocytopenia

scientific article

Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome

scientific article

First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat

scientific article

Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases

scientific article

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

scientific article

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature

scientific article

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from literature analysis

scientific article

How I treat von Willebrand disease

scientific article published on 27 May 2009

ITP and international guidelines: what do we know, what do we need?

scientific article

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

scientific article published on 14 March 2008

Immune thrombocytopenia in lymphoproliferative disorders

scientific article

Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.

scientific article

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

scientific article

International consensus report on the investigation and management of primary immune thrombocytopenia

scientific article

Is ITP a thrombophilic disorder?

scientific article

Long‐term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials ⬇️

scientific article published on September 17, 2013

Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia

scientific article published on 20 June 2012

Multivariate statistical data analysis as a tool to analyze ex vivo expansion dynamics of cytokine-induced killer cells

scientific article

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

scientific article

Optimizing treatment of von Willebrand disease by using phenotypic and molecular data

scientific article

Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future

scientific article

Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

scientific article published on February 2004

Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations

scientific article

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

scientific article

Recurrence of the 'deep-intronic' FGG IVS6-320A>T mutation causing quantitative fibrinogen deficiency in the Italian population of Veneto

scientific article

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia ⬇️

scientific article published on November 11, 2010

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

scientific article

Short‐ and long‐term risks of splenectomy for benign haematological disorders: should we revisit the indications? ⬇️

scientific article published on May 10, 2012

Side effects of anti-angiogenic drugs ⬇️

scientific article published on April 1, 2012

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

scientific article

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

scientific article

TPO-receptor agonists in ITP: a clinician's navigation between Scylla and Charybdis

scientific article

The European Hematology Association Roadmap for European Hematology Research: a consensus document

scientific article

The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia

scientific article

The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases

scientific article

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience

scientific article

Treatment of immune thrombocytopenia in adults: the role of thrombopoietin-receptor agonists

scientific article

Treatment of von Willebrand disease

scientific article

Treatment practices in adults with chronic immune thrombocytopenia - a European perspective

scientific article

Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment

scientific article

List of works by Francesco Rodeghiero

A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.

A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene

A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiency

Advances in the diagnosis and management of type 1 von Willebrand disease ⬇️

Assessing bleeding in von Willebrand disease with bleeding score

Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?

Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.

Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia

Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation

Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults

Economic assessment of eltrombopag in the treatment of thrombocytopenia

Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome

First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat

Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from literature analysis

How I treat von Willebrand disease

ITP and international guidelines: what do we know, what do we need?

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

Immune thrombocytopenia in lymphoproliferative disorders

Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

International consensus report on the investigation and management of primary immune thrombocytopenia

Is ITP a thrombophilic disorder?

Long‐term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials ⬇️

Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia

Multivariate statistical data analysis as a tool to analyze ex vivo expansion dynamics of cytokine-induced killer cells

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

Optimizing treatment of von Willebrand disease by using phenotypic and molecular data

Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future

Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

Recurrence of the 'deep-intronic' FGG IVS6-320A>T mutation causing quantitative fibrinogen deficiency in the Italian population of Veneto

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia ⬇️

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

Short‐ and long‐term risks of splenectomy for benign haematological disorders: should we revisit the indications? ⬇️

Side effects of anti-angiogenic drugs ⬇️

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

TPO-receptor agonists in ITP: a clinician's navigation between Scylla and Charybdis

The European Hematology Association Roadmap for European Hematology Research: a consensus document

The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia

The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience

Treatment of immune thrombocytopenia in adults: the role of thrombopoietin-receptor agonists

Treatment of von Willebrand disease

Treatment practices in adults with chronic immune thrombocytopenia - a European perspective

Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment